FemTech Insight Digest

Clinical Research Signals

• 🔥 OSE Phase 2 Ovarian Data: OSE Immunotherapeutics reported phase 2 results showing OSE2101 plus Keytruda improved...

OSE2101 plus Keytruda delivered 4.1 months PFS versus 2.8 months with best supportive care in recurrent ovarian cancer maintenance. The approach of...

Summit data and advocacy now converge on clear economic stakes.

• Menopause costs mount: Unmanaged symptoms drive mental health issues, chronic...

Emmeline Ventures' vision holds that funding more women unlocks future growth and removes barriers to opportunity in women's health innovation. This targeted approach signals expanding market potential for FemTech investors.

Midlife Clinical Screening Details

• 🔥 Health Screenings For Women In Midlife: A meaningful cardiovascular screening includes blood pressure...

Gaps in women's health research and care are fueling a vaginal wellness market projected to double or triple this decade, with DTC products like...

A meaningful cardiovascular screening for midlife women includes blood pressure measurement and a fasting lipid panel covering total cholesterol, LDL, HDL, and triglycerides. This targeted approach enables practical implementation in routine care.

Menopause triggers measurable shifts in memory, focus, and mood through estrogen’s direct role in brain function, with women comprising 60% of...

Maternal Health Policy Shifts

• 🔥 Removal of 'Black' from Momnibus Bills: The word 'Black' has been almost completely removed from the latest...

The latest Momnibus Act has dropped most references to 'Black' from its title and text, evolving from over a dozen mentions in 2020 to just one in...

Dr. Mary Claire Haver translates complex research into practical strategies for perimenopause and post-menopause, emphasizing quality of life and...

Dr. Christine Vaccaro highlights how women's sexual health remains poorly understood, urging clearer conversations on hormones, libido, and pelvic...

MENA Funding Activity

• 🔥 RSA XB Seed Round: UAE-based RSA XB raised $1.5 million in a seed round led by 21 Ventures and spun off from RSA Global...

The Founder Institute implements a unique gender-blind evaluation model for its pre-seed program to ensure applicants are judged solely on merit and...

Women's health R&D receives just one-fifth of total funding, with most concentrated in ovarian cancer and menopause, leaving conditions like ischemic...

UAE-based RSA XB's $1.5 million seed round, spun off from RSA Global and led by 21 Ventures, offers a clear emerging-market model of cross-border health logistics innovation with direct implications for reimbursement and health-system implementation.

Research calls targeting menopausal disorders are generating new knowledge across the life course, while plan sponsors explore dedicated midlife...

US Policy Shift in Menopause Care

• 🔥 Advancing Menopause Care and Mid-Life Women's Health Act: The Act introduces new US public funding and...

Emily's $250M AUM VC team targets women's health alongside Medicare and Medicaid to navigate health plan innovation failures and drive scalable adoption.

Hormone shifts in perimenopause are worsening IBS and gut symptoms by altering the microbiome, digestion, and inflammation.

• Experts link...